These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12237324)

  • 1. Conformation of ligands bound to the muscarinic acetylcholine receptor.
    Furukawa H; Hamada T; Hayashi MK; Haga T; Muto Y; Hirota H; Yokoyama S; Nagasawa K; Ishiguro M
    Mol Pharmacol; 2002 Oct; 62(4):778-87. PubMed ID: 12237324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
    Vogel WK; Sheehan DM; Schimerlik MI
    Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of charge interactions in muscarinic agonist binding, and receptor-response coupling.
    Hulme EC; Curtis CA; Page KM; Jones PG
    Life Sci; 1995; 56(11-12):891-8. PubMed ID: 10188790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis.
    Page KM; Curtis CA; Jones PG; Hulme EC
    Eur J Pharmacol; 1995 May; 289(3):429-37. PubMed ID: 7556411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese Hamster ovary cell membranes: 2. Testing the "two-states" model of receptor activation.
    Waelbroeck M
    Mol Pharmacol; 2001 Apr; 59(4):886-93. PubMed ID: 11259634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
    Mistry R; Dowling MR; Challiss RA
    Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the functional complexes of m2 muscarinic acetylcholine receptors with GTP-binding regulatory proteins in solution.
    Rinken A
    J Biochem; 1996 Jul; 120(1):193-200. PubMed ID: 8864864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic and nicotinic cholinergic agonists: structural analogies and discrepancies.
    Bikádi Z; Simonyi M
    Curr Med Chem; 2003 Dec; 10(23):2611-20. PubMed ID: 14529475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic signaling pathway for calcium release and calcium-activated chloride current in smooth muscle.
    Wang YX; Kotlikoff MI
    Am J Physiol; 1997 Aug; 273(2 Pt 1):C509-19. PubMed ID: 9277348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice.
    Chen SR; Wess J; Pan HL
    J Pharmacol Exp Ther; 2005 May; 313(2):765-70. PubMed ID: 15665136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.
    Duttaroy A; Gomeza J; Gan JW; Siddiqui N; Basile AS; Harman WD; Smith PL; Felder CC; Levey AI; Wess J
    Mol Pharmacol; 2002 Nov; 62(5):1084-93. PubMed ID: 12391271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
    Richardson RM; Mayanil CS; Hosey MM
    Mol Pharmacol; 1991 Dec; 40(6):908-14. PubMed ID: 1758442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-dependent delivery of M(2) muscarinic acetylcholine receptors to the cell surface after pertussis toxin treatment.
    Roseberry AG; Bünemann M; Elavunkal J; Hosey MM
    Mol Pharmacol; 2001 May; 59(5):1256-68. PubMed ID: 11306711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conformational switch in muscarinic acetylcholine receptors.
    Hulme EC; Lu ZL; Bee M; Curtis CA; Saldanha J
    Life Sci; 2001 Apr; 68(22-23):2495-500. PubMed ID: 11392618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conformational and property space of acetylcholine bound to muscarinic receptors: an entropy component accounts for the subtype selectivity of acetylcholine.
    Vistoli G; Pedretti A; Testa B; Matucci R
    Arch Biochem Biophys; 2007 Aug; 464(1):112-21. PubMed ID: 17544360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.
    Sauerberg P; Olesen PH; Sheardown MJ; Rimvall K; Thøgersen H; Shannon HE; Sawyer BD; Ward JS; Bymaster FP; DeLapp NW; Calligaro DO; Swedberg MD
    J Med Chem; 1998 Jan; 41(1):109-16. PubMed ID: 9438027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
    Huang XP; Williams FE; Peseckis SM; Messer WS
    Mol Pharmacol; 1999 Oct; 56(4):775-83. PubMed ID: 10496961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.